 thrombolyt pharmacokinet properti conjug recombin single-chain urokinase-typ plasminogen activ monoclon antibodi specif cross-link fibrin baboon venou thrombosi model chemic conjug recombin single-chain urokinase-typ plasminogen activ rscu-pa murin monoclon antibodi fragment d-dimer cross-link human fibrin rscu-pa control monoclon antibodi n-succinimidyl propion spdp vitro system fibrin-label baboon plasma clot autolog citrat plasma dose- time-depend lysi ratio potenc free rscu-pa similar human plasma lysi hour micrograms/ml rscu-pa microgram/ml urokinase-typ plasminogen activ u-pa equival micrograms/ml u-pa equival thrombolyt pharmacokinet properti rscu-pa baboon ml fibrin-label autolog blood clot femor vein continu intraven infus compound period dose- time-depend lysi thrombolyt potenc time lysi mg u-pa equivalent/kg bodi wt rscu-pa ex vivo recoveri femor vein segment time lysi mg/kg extern radioisotop count dose mg/kg activ end infus u-pa-rel antigen plasma biphas manner initi half-tim rscu-pa minut plasma clearanc ml/min conclus thrombolyt potenc result reduct thrombolyt potenc due rscu-pa antibodi molecul counter-balanc enhanc thrombolyt potenc due specif idiotyp